Skip to main content
. Author manuscript; available in PMC: 2013 Mar 2.
Published in final edited form as: Ann Neurol. 2012 Apr 9;71(6):765–775. doi: 10.1002/ana.22628

Figure 2.

Figure 2

Box plots with individual data points for PIB (panel A), FDG (panel B), and HVa (panel C). Arrows in each panel indicate the biomarker cut-points for five levels of AD sensitivity ranging from 80% to 99%.